{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:01:55Z","timestamp":1780362115665,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.canlet.2012.09.016","type":"journal-article","created":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T19:54:47Z","timestamp":1348775687000},"page":"36-43","source":"Crossref","is-referenced-by-count":8,"title":["Functional inactivation of Rb sensitizes cancer cells to TSC2 inactivation induced cell death"],"prefix":"10.1016","volume":"328","author":[{"given":"Arpad M.","family":"Danos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2012.09.016_b0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tibs.2004.06.006","article-title":"E2F target genes: unraveling the biology","volume":"29","author":"Bracken","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2012.09.016_b0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s13238-011-1117-z","article-title":"Conserved RB functions in development and tumor suppression","volume":"2","author":"Gordon","year":"2011","journal-title":"Protein Cell"},{"key":"10.1016\/j.canlet.2012.09.016_b0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1469-1809.2003.00012.x","article-title":"Tuberous sclerosis: from tubers to mTOR","volume":"67","author":"Kwiatkowski","year":"2003","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.canlet.2012.09.016_b0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2010.03.019","article-title":"Specific killing of Rb mutant cancer cells by inactivating TSC2","volume":"17","author":"Li","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2012.09.016_b0025","first-page":"773","article-title":"Targeting Rb inactivation in cancers by synthetic lethality","volume":"1","author":"Gordon","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2012.09.016_b0030","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0022-2143(96)90092-X","article-title":"Cyclin D1\/PRAD1 as a central target in oncogenesis","volume":"127","author":"Hosokawa","year":"1996","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.canlet.2012.09.016_b0035","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.juro.2011.10.149","article-title":"P16(INK4a) is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study","volume":"187","author":"Gunia","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2012.09.016_b0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00405-004-0831-z","article-title":"The effect of cyclin D1 overexpression in human head and neck cancer cells","volume":"262","author":"Nakashima","year":"2005","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.canlet.2012.09.016_b0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.virol.2008.10.006","article-title":"The human papillomavirus E7 oncoprotein","volume":"384","author":"McLaughlin-Drubin","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2012.09.016_b0050","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.virol.2008.12.006","article-title":"Small DNA tumor viruses: large contributors to biomedical sciences","volume":"384","author":"Howley","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.canlet.2012.09.016_b0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/334124a0","article-title":"Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product","volume":"334","author":"Whyte","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2012.09.016_b0060","doi-asserted-by":"crossref","first-page":"10848","DOI":"10.1073\/pnas.1831408100","article-title":"Specificity in the activation and control of transcription factor E2F-dependent apoptosis","volume":"100","author":"Hallstrom","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.09.016_b0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2007.11.031","article-title":"An E2F1-dependent gene expression program that determines the balance between proliferation and cell death","volume":"13","author":"Hallstrom","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2012.09.016_b0070","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/bjc.2011.605","article-title":"Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer","volume":"106","author":"Ettl","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2012.09.016_b0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.semcancer.2008.11.010","article-title":"Is akt the \u201cwarburg kinase\u201d? akt-energy metabolism interactions and oncogenesis","volume":"19","author":"Robey","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2012.09.016_b0080","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ccr.2008.11.003","article-title":"Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis","volume":"14","author":"Nogueira","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2012.09.016_b0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archotol.130.1.68","article-title":"Short hairpin RNA system to inhibit human p16 in squamous cell carcinoma","volume":"130","author":"Shin","year":"2004","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.canlet.2012.09.016_b0090","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1158\/0008-5472.CAN-09-0042","article-title":"Loss of phosphatase and tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer","volume":"69","author":"Miller","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.09.016_b0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/hum.2010.068","article-title":"Creating higher titer lentivirus with caffeine","volume":"22","author":"Ellis","year":"2011","journal-title":"Hum. Gene. Ther."},{"key":"10.1016\/j.canlet.2012.09.016_b0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4161\/cbt.72","article-title":"Cycling to cancer with cyclin D1","volume":"1","author":"Diehl","year":"2002","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2012.09.016_b0105","first-page":"16","article-title":"Establishment and characterization of a human prostatic carcinoma cell line (PC-3)","volume":"17","author":"Kaighn","year":"1979","journal-title":"Invest. Urol."},{"key":"10.1016\/j.canlet.2012.09.016_b0110","first-page":"2780","article-title":"Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha","volume":"51","author":"Hofer","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2012.09.016_b0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00280-003-0726-5","article-title":"Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity","volume":"53","author":"Hileman","year":"2004","journal-title":"Cancer Chemoth. Pharm."},{"key":"10.1016\/j.canlet.2012.09.016_b0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"ROS stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2012.09.016_b0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrc3037","article-title":"PTEN loss in the continuum of common cancers, rare syndromes and mouse models","volume":"11","author":"Hollander","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2012.09.016_b0130","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1073\/pnas.0602282103","article-title":"TSC1\/TSC2 and Rheb have different effects on TORC1 and TORC2 activity","volume":"103","author":"Yang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2012.09.016_b0135","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","article-title":"Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies","volume":"14","author":"Shah","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2012.09.016_b0140","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tcb.2008.08.003","article-title":"E2F - at the crossroads of life and death","volume":"18","author":"Polager","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2012.09.016_b0145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ydbio.2008.11.035","article-title":"Regulation of apoptosis of rbf mutant cells during Drosophila development","volume":"326","author":"Tanaka-Matakatsu","year":"2009","journal-title":"Dev. Biol."},{"key":"10.1016\/j.canlet.2012.09.016_b0150","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.4161\/cc.9.20.13454","article-title":"RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response","volume":"9","author":"Ertel","year":"2010","journal-title":"Cell Cycle"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512005654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512005654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T08:23:52Z","timestamp":1542702232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383512005654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0304383512005654"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2012.09.016","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}